Flu vaccination, as well as being effective to prevent seasonal influenza, decreases staff illness and absenteeism and reduces costs resulting from loss of productivity. Despite the effectiveness of flu vaccination, the seasonal coverage among healthcare workers is usually low. The aim of this retrospective observational study is to analyze the vaccination coverage rate among all employees (healthcare workers and administrative staff) of a large teaching hospital in Rome during the 2017-2018 influenza season, to perform a cost-consequence analysis of influenza vaccination (by evaluating the absenteeism due to illness in the epidemic period), and to assess the impact of vaccination in terms of both costs and sick days.
Study Type
OBSERVATIONAL
Enrollment
5,483
Administration of quadrivalent split inactivated non-adjuvanted flu vaccine Fluarix Tetra
Fondazione Policlinico Universitario "A.Gemelli" IRCCS
Rome, Italy
Effectiveness of the quadrivalent vaccine
Effectiveness of the quadrivalent vaccine in reducing the number of working days lost due to influenza syndrome
Time frame: 33 weeks
Economic impact of the quadrivalent vaccine
Economic impact (for the company and society) of vaccination as part of a vaccination campaign on the healthcare workers of the teaching hospital.
Time frame: 33 weeks
Expected economic savings for each one percentage point increase in vaccination coverage
Expected economic savings for each one percentage point increase in coverage on the health personnel of the teaching hospital
Time frame: 33 weeks
Non-economic incentives for healthcare personnel who decide to vaccinate
Non-economic incentives for healthcare personnel who decide to vaccinate, in view of the financial savings for the company, linked to increased vaccination coverage
Time frame: 33 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.